Sharing Life Sciences Innovations
How do we reduce the high cost of clinical trials?
Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. Why are clinical trials so insanely expe…
Living on the edge: the challenge of doing things differently in cell therapy
Belgian company Celyad is a trailblazer in oncology: its T cell therapies based on NK receptors are cutting edge even for CAR-T. At the Science for health event in September the visionary Christia…
Solving food waste one StixFresh sticker at a time
Food waste is a major global issue exacerbated by premature fruit spoilage. A US company, StixFresh, is working together with VIB-KU Leuven Prof Patrick Van Dijck to develop a solution to the prob…
Gilead and Galapagos enter into transformative research and development collaboration
Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment Gilead Gains Access to Galapagos’ Differentiated Drug Discovery Platform and Current and Future Pipeline O…
WELBIO joins ranks with celebrities after a new bacterium is named after the institute
WELBIO has received a truly unique form of acknowledgement: a newly discovered bacterium has been named after the research institute. The human gut microbe was discovered during a project led by P…
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
Ghent, Belgium, and Dresden, Germany - 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-pro…
Edible antibodies to prevent and treat gut diseases
Belgian researchers have developed edible antibodies that can prevent gut bacterial infections. Normally antibodies need to be injected, but the antibodies developed by Dr. Vikram Virdi in the gro…
A new type of power plants to combat climate change
The prestigious organization EMBO recently announced several new members, including the appointment of VIB-UGent scientist Prof Wout Boerjan. Boerjan joins over 1800 other EMBO members in what is …
Miracle microchips improving cell therapy manufacturing
A microchip engineer might seem like an odd fit for a keynote speaker at an event focused on cell therapy, but at Science for health Peter Peumans will be presenting one of the day’s visionary tal…
OCTIMET Oncology tackling cancer with a new captain at the helm
In this VC Views article, V-Bio Ventures introduces one of their portfolio companies, OCTIMET. This Belgian oncology startup just added a new member to its executive team, with the appointment of …
Stellar year for Belgian biotech
Belgium has once again strengthened its position as Europe's biotech leader. Today, Belgian biotech companies comprise 23 percent of the total market value of all public European biotech companies…
Join our mailing list and receive the monthly BioVox newsletter for free!
Upcoming events
Science for health 2019
SQUARE Brussels
Wed 11 Sep 2019
10:00
Health science is about the patient; about preventing illness and saving lives. Collaboration and out-of-the-box thinking accelerate progress. This yearly event connects researchers and clinicians…
VFB Investor Congress "Dag van de Tips"
Gent ICC
Van Rysselberghedreef 2
9000 Gent
Sat 28 Sep 2019
08:30
VFB Investor Congress "Dag van de Tips" (Expert Tips Day) will take place on September the 28th in the beautiful Ghent ICC! Bank analysts, stock exchange houses, investment magazines and VFB …
CRIG Industrial partnering event 2019
Auditorium 4
Sint-Denijslaan 485
9000 Gent
Belgium
Fri 25 Oct 2019
08:00
The Cancer Research Institute Ghent (CRIG) welcomes you to its 2nd industrial partnering event! We are pleased to announce the 2nd edition of the Cancer Research Institute Ghent (CRIG) industr…
